|
|
Volumn 32, Issue 7, 2014, Pages 607-
|
|
Green light for Janssen's IL-6 blocker.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INTERLEUKIN 6 RECEPTOR;
MONOCLONAL ANTIBODY;
SILTUXIMAB;
ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA;
BELGIUM;
CLINICAL TRIAL (TOPIC);
DRUG ANTAGONISM;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
MULTIPLE MYELOMA;
NOTE;
TREATMENT OUTCOME;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
BELGIUM;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
GIANT LYMPH NODE HYPERPLASIA;
MULTIPLE MYELOMA;
RECEPTORS, INTERLEUKIN-6;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84908141612
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0714-607b Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|
